1. 2022-LBA-414-ESGO Preliminary clinical outcome of ADP-A2M4CD8, a next-generation autologous T-cell receptor T-cell therapy, in patients with advanced epithelial ovarian cancer. (27th October 2022) Authors: Moore, Kathleen; Asch, Adam; Moreno, Victor; Calvo, Emiliano; Butler, Marcus; Zugazagoitia, Jon; Hong, David; Galal, Ahmed; Ostios, Lorena; de Miguel, Maria; Lin, Quan; Annareddy, Thejo; Brophy, Francine; Rosenberg, Marisa; Seiders, Theresa; Naidoo, Revashnee; Bath, Natalie; Saro, Jose; Norry, El... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines. (4th March 2017) Authors: Klein, Christian; Waldhauer, Inja; Nicolini, Valeria G.; Freimoser-Grundschober, Anne; Nayak, Tapan; Vugts, Danielle J.; Dunn, Claire; Bolijn, Marije; Benz, Jörg; Stihle, Martine; Lang, Sabine; Roemmele, Michaele; Hofer, Thomas; van Puijenbroek, Erwin; Wittig, David; Moser, Samuel; Ast, Oliver; B... Journal: Oncoimmunology Issue: Volume 6:Number 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ITOC2 – 037. CEA TCB, A novel T-cell bispecific antibody with potent in vitro and in vivo antitumour activity against solid tumours. (March 2015) Authors: Bacac, Marina; Fauti, Tanja; Colombetti, Sara; Sam, Johannes; Nicolini, Valeria; Steinhoff, Nathalie; Ast, Oliver; Bruenker, Peter; Hosse, Ralf; Hofer, Thomas; Moessner, Ekkehard; Jaeger, Christiane; Saro, Jose; Karanikas, Vaios; Klein, Christian; Umaña, Pablo Journal: European journal of cancer Issue: Volume 51(2015)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗